Compare ELVN & FWRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELVN | FWRG |
|---|---|---|
| Founded | 2016 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 768.7M |
| IPO Year | 2020 | 2021 |
| Metric | ELVN | FWRG |
|---|---|---|
| Price | $49.92 | $10.11 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 13 |
| Target Price | ★ $43.40 | $20.46 |
| AVG Volume (30 Days) | 804.1K | ★ 894.7K |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 3.17 | ★ 3.33 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,222,501,000.00 |
| Revenue This Year | N/A | $15.58 |
| Revenue Next Year | N/A | $12.81 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 20.34 |
| 52 Week Low | $14.79 | $9.97 |
| 52 Week High | $62.32 | $18.82 |
| Indicator | ELVN | FWRG |
|---|---|---|
| Relative Strength Index (RSI) | 26.54 | 34.23 |
| Support Level | $25.63 | $10.22 |
| Resistance Level | $52.39 | $13.47 |
| Average True Range (ATR) | 2.22 | 0.58 |
| MACD | -1.27 | -0.18 |
| Stochastic Oscillator | 9.17 | 14.67 |
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
First Watch Restaurant Group Inc is a daytime restaurant concept serving made-to-order breakfast, brunch, and lunch using fresh ingredients. The company generates revenues from Restaurant sales and Franchise revenues. It generates maximum revenue from Restaurant sales.